Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

Mikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G. +4 more·2015·Nature Communications

DOI 10.1038/ncomms8458

Cited by (512)

Items 301–400 of 512

ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
Hae-Yun Jung, Dae-Keum Lee, Minwook Lee, Seung Hee Choi, Joo Dong Park, Eun-Su Ko, Jong Won Lee, Kyung‐Soon Park, Hae‐Yun Jung · 2023 · OncoImmunology
CXCL10Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10
Lianbo Li, Kosuke Kanemitsu, Koji Ohnishi, Rin Yamada, Hiromu Yano, Yukio Fujiwara, Yuji Miyamoto, Yoshiki Mikami, Taizo Hibi, Hideo Baba et al. · 2023 · Cancer Genomics & Proteomics
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design
Anna Gaimari, Anna De Lucia, F. Nicolini, Luciana Mazzotti, R. Maltoni, Giovanna Rughi, Matteo Zurlo, Matteo Marchesini, M. Juan, D. Parras et al. · 2024 · International Journal of Molecular Sciences
cDC1 dysregulation in cancer: An opportunity for intervention
Thomas Frank Gajewski, Kyle R. Cron · 2020 · The Journal of Experimental Medicine
Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
Benjamin Motais, Sandra Charvátová, Zuzana Walek, Matouš Hrdinka, Ryszard Smolarczyk, Tomasz Cichoń, Justyna Czapla, Sebastian Giebel, Michal Šimíček, Tomáš Jelı́nek et al. · 2021 · Cells
Chemokines that govern T cell activity in tumors
Thorsten R. Mempel, Mohsen Malehmir · 2024 · Current Opinion in Immunology
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
Brendan Zangari, Takemasa Tsuji, Junko Matsuzaki, Hemn Mohammadpour, Cheryl Eppolito, Sebastiano Battaglia, Fumito Ito, Thinle Chodon, Richard Chikara Koya, AJ Robert McGray et al. · 2022 · Cancer Immunology Immunotherapy
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate
Adam L. Burrack, Ellen J. Spartz, Meagan R. Rollins, Ebony A. Miller, Maria M. Firulyova, Eduardo Cruz-Hinojoza, Michael F. Goldberg, Iris Wang, Hezkiel A. Nanda, Steven Shen et al. · 2022 · Cancer Immunology Immunotherapy
Huang-Jin-Shuang-Shen Decoction promotes CD8+ T-cell-mediated anti-tumor immunity by regulating chemokine CXCL10 in gastric cancer
Chuqi Yang, Xuefei Xu, Mengting Wu, Zhengqi Zhao, Yewen Feng, Weiyu Liang, XU Chu-yun, Tao Jiang, Guangji Zhang · 2024 · Phytomedicine
CX3CR1 + CD8 + T cells: Key players in antitumor immunity
Jiajin Ma, Yue Wu, Shaoxian Wu, Fang Zhang, Lujun Chen, Jingting Jiang, Xiao Zheng · 2024 · Cancer Science
Switching on the green light for chimeric antigen receptor T‐cell therapy
Sherly Mardiana, Junyun Lai, Imran G. House, Paul A. Beavis, Phillip Kevin Darcy · 2019 · Clinical & Translational Immunology
Ablation of T cell–associated PD-1H enhances functionality and promotes adoptive immunotherapy
Li Hu, Ling Chen, Zexiu Xiao, Zheng Xu, Yuangui Chen, Na Xian, Christina Cho, Liqun Luo, Gangxiong Huang, Lieping Chen · 2021 · JCI Insight
C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration
Xi Cao, Yu Song, Huanwen Wu, Xinyu Ren, Qiang Sun, Zhiyong Liang · 2023 · Molecular Cancer Therapeutics
Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions
Duy Nguyen, Ruixuan Liu, Elizabeth Ogando‐Rivas, Alfonso Pepe, Diego Ivan Pedro, Sadeem Qdaisat, Nhi Tran Yen Nguyen, Julia M. Lavrador, Griffin R. Golde, Ryan A. Smolchek et al. · 2023 · Acta Biomaterialia
Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors
Tatsuki Ueda, Shin Kaneko · 2020 · International Journal of Hematology
Motility Matters: How CD8+ T-Cell Trafficking Influences Effector and Memory Cell Differentiation
Yagmur Farsakoglu, Bryan McDonald, Susan M. Kaech · 2021 · Cold Spring Harbor Perspectives in Biology
IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Van Anh Do-Thi, Sang Min Park, Song Mi Park, Hye Jin Jeong, Geunyoung Cho, Hyun‐Jung An, Young Sang Kim, Hayyoung Lee, Jie‐Oh Lee · 2023 · Cancer Research Communications
Gene-activating nanomedicine for the tumor-oriented infiltration of T cells to enhance immunotherapy against solid tumors
Yue Zhang, Gui Zhao, Jing Liu, Houbing Zhang, Yue Wang, Ying‐Li Luo, Zi-Dong Lu, Zi-Dong Lu, Song Shen, Jin‐Zhi Du et al. · 2023 · Nano Today
Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway
Y Zhang, Heng Zhao, Weili Deng, Junzhong Lai, Kai Sang, Qi Chen · 2024 · Communications Biology
A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC
Zhengyang Zhou, Hongdian Zhang, Jian Du, Jiayu Yang, Wen Pan, Qiumo Zhang, Huiya Wang, Peng Tang, Yi Ba, Haiyang Zhang · 2024 · Cell Death and Disease
Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells
Peter M. Sullivan, Steven James Reed, Vandana Kalia, Surojit Sarkar · 2021 · Frontiers in Immunology
C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease
Albert Frank Magnusen, Reena Rani, Mary Ashley McKay, Shelby Loraine Hatton, Tsitsi Carol Nyamajenjere, Daniel Nii Aryee Magnusen, Jörg Köhl, Gregory Alex Grabowski, Manoj K. Pandey · 2021 · International Journal of Molecular Sciences
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
Rebecca Adams, Bernhard Moser, Sophia N. Karagiannis, Katie E. Lacy · 2021 · Cancers
Tumor necrosis factor receptor regulation of peripheral node addressin biosynthetic components in tumor endothelial cells
Anthony B. Rodriguez, Geoffrey Parriott, Víctor H. Engelhard · 2022 · Frontiers in Immunology
Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy
Hyein Jeong, So-Young Lee, Hyejun Seo, Dong Hyun Kim, Duhyung Lee, Bum-Joon Kim · 2022 · OncoImmunology
Contemporary Approaches to Immunotherapy of Solid Tumors
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, Белецкий Игорь Петрович, Ivanov Aa · 2024 · Cancers
Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer
Jiayun Li, Philip Moresco, Douglas T. Fearon · 2024 · Proceedings of the National Academy of Sciences
Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity
Mayra Cecilia Suárez-Arriaga, Alfonso Méndez-Tenorio, Vadim Pérez‐Koldenkova, Ezequiel M. Fuentes‐Pananá · 2021 · Cancers
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies
Andrew C. Cannon, Christopher M. Thompson, Rakesh Bhatia, Rakhee Rathnam Kalari Kandy, Joyce C. Solheim, Surinder K. Batra, Sushil Kumar K · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
Maryann E. Mikucki, Joseph J. Skitzki, John G. Frelinger, Kunle O. Odunsi, Thomas Frank Gajewski, Andrew David Luster, Sharon S. Evans · 2016 · OncoImmunology
Enhanced CXCR4 Expression of Human CD8Low T Lymphocytes Is Driven by S1P4
Tobias Burkard, Caroline Dreis, Martina Herrero San Juan, Meik Huhn, Andreas Weigert, Josef M. Pfeilschifter, Heinfried H. Radeke · 2021 · Frontiers in Immunology
Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors
Elnaz Khodabandehloo, Mohammad Rayati, Ehsan Ahmadi, Mohammadjavad Naghdibadi, Vahid Moradi, Naser Ahmadbeigi · 2025 · Inflammation and Regeneration
Reversing Chemokine/Chemokine Receptor Mismatch to Enhance the Antitumor Efficacy of CAR-T Cells
Pengfei Zhang, Chuang Wang, Le Zhang, Qiu Li · 2022 · Immunotherapy
Advances in bioengineered CAR T/ NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/ NK cell therapy
Nasim Dana, Arezou Dabiri, Majed Bahri Najafi, Azadeh Rahimi, Sayed Mohammad Matin Ishaghi, Laleh Shariati, Minmin Shao, Assunta Borzacchiello, Ilnaz Rahimmanesh, Pooyan Makvandi · 2024 · Bioengineering & Translational Medicine
Comparative analyses for plant virus-based cancer immunotherapy drug development
Anthony O. Omole, Hannah S. Newton, Edward Cedrone, Kimia Nematpour, Shaojun Xie, Yongmei Zhao, Bao Tran, Marina A. Dobrovolskaia, Nicole F. Steinmetz · 2025 · Cell Biomaterials
Resident Memory T Cells in the Tumor Microenvironment
Jason B. Williams, Thomas Seth Kupper · 2020 · Advances in experimental medicine and biology
Immune Checkpoint Proteins, Metabolism and Adhesion Molecules: Overlooked Determinants of CAR T-Cell Migration?
Luca Simula, Emma Ollivier, Philippe Icard, Emmanuel Donnadieu · 2022 · Cells
A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers
Manoharan, Malini, Mandloi, Nitin, Priyadarshini, Sushri, Patil, Ashwini, Gupta, Rohit, Iyer, Laxman, Gupta, Ravi, Chaudhuri, Amitabha · 2018 · Frontiers in Immunology
Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma
Cheyanne K. Shinn, Robert Saddawi‐Konefka, Catherina L. Salanga, Shiruyeh Schokrpur, Jorge Silvio Gutkind, Tracy M. Handel · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy
Jun‐Eul Hwang, Sung Sun Kim, Hyun-Jin Bang, Hyeon-Jong Kim, Hyun-Jeong Shim, Woo‐Kyun Bae, Ik‐Joo Chung, Eun Gene Sun, Taebum Lee, Chan‐Young Ock et al. · 2024 · Cancers
Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, Katherine S. Lee, Bishal Misra, Sharan Kumar Reddy Bobbala, Fredrick Heath Damron, Tracy W. B. Liu · 2025 · Scientific Reports
A rational relationship: Oncolytic virus vaccines as functional partners for adoptive T cell therapy
Rebecca Burchett, Scott R. Walsh, Yonghong Wan, Jonathan L. Bramson · 2020 · Cytokine & Growth Factor Reviews
CXCR3 Expression and Genome-Wide 3′ Splice Site Selection in the TCGA Breast Cancer Cohort
Lauren A. Levesque, Scott William Roy, Nicole Salazar · 2021 · Life
Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma
Weijiang Fu, Guangxin Ma · 2022 · Frontiers in Genetics
The show and tell of cross-presentation
Julie Magarian Blander, Kristel Joy Yee Mon, Atimukta Jha, Dylan Roycroft · 2023 · Advances in immunology
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma
Florian Hornsteiner, Janine Vierthaler, Helen Strandt, Antonia Resag, Zhe Fu, Markus Außerhofer, Christoph H. Tripp, Sophie Marie Dieckmann, Markus Kanduth, Kathryn J. Farrand et al. · 2024 · Journal for ImmunoTherapy of Cancer
Preferential Small Intestine Homing and Persistence of CD8 T Cells in Rhesus Macaques Achieved by Molecularly Engineered Expression of CCR9 and ReducedEx VivoManipulation
Matthew T. Trivett, J. D. Burke, Claire Deléage, Lori V. Coren, Brenna J. Hill, Sumiti Jain, Eugene V. Barsov, Matthew W. Breed, Joshua A Kramer, Gregory Q. Del Prete et al. · 2019 · Journal of Virology
Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation
Karolina Pyziak, Agnieszka Sroka‐Porada, Tomasz Rzymski, Józef Dulak, Agnieszka Łoboda · 2021 · Drug Development Research
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
Long Chen, Fukun Chen, Huatao Niu, Jindan Li, Yongzhu Pu, Conghui Yang, Yue Wang, Rong Huang, Ke Li, Yujie Lei et al. · 2022 · Frontiers in Immunology
Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment
Franziska Füchsl, Angela M. Krackhardt · 2022 · Cancers
The soldiers needed to be awakened: Tumor-infiltrating immune cells
Wang Yaping, Zhe Wang, Chu Zhuling, Ruolei Li, Fan Pengyu, Guo Lili, Ji Cheng, Zhang Bo, Liuyin Liu, Hou Guangdong et al. · 2022 · Frontiers in Genetics
Recruitment of Intratumoral CD103+ Dendritic Cells by a CXCR4 Antagonist-Armed Virotherapy Enhances Antitumor Immunity
Anna Mistarz, Marcin P. Komorowski, Matthew A. Graczyk, Margaret Gil, Aimin Jiang, Mateusz Opyrchal, Hanna Rokita, Kunle O. Odunsi, Danuta Kozbor · 2019 · Molecular Therapy — Oncolytics
Prognostic Roles of Phosphofructokinase Platelet in Clear Cell Renal Cell Carcinoma and Correlation with Immune Infiltration
Bin Liu, Faping Li, Mingdi Liu, Zhixiang Xu, Baoshan Gao, Yishu Wang, Honglan Zhou · 2021 · International Journal of General Medicine
KRAS mRNA Spleen‐Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in Pancreatic Cancer
Lijia Luo, Xiang Wang, Yu‐Pei Liao, André E. Nel · 2025 · Advanced Science
Particle Shape Modulates the Function of Adoptive Macrophage Transfers
Matthew M. C. Kwan, Nicole B. Day, Iain R. Konigsberg, Evan Thoresen, Abigail M. Harrell, Celeste E. Busch, Elizabeth Davidson, Ivana V. Yang, Charles Wyatt Shields · 2025 · Advanced Healthcare Materials
LSD1 Inhibition Induces MHC-I and Dendritic Cell Activation to Promote Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
Amit Kumar Chakraborty, Lina Kroehling, Rajnikant Dilip Raut, Chumki Choudhury, Maria A. Kukuruzinska, Jorge Silvio Gutkind, Xaralabos Varelas, Bikash Sahay, Stefano Monti, Manish V. Bais · 2025 · Cancer Research
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Sho Matoya, Tomokatsu Miyaki, Yoshihide Kimura, Atsunori Kusakabe et al. · 2023 · Cancer Medicine
An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial
Anton Lahusen, Manfred Paul Lutz, Rui Fang, Martina Kirchner, Sarah Albus, Klaus Kluck, Meinolf Karthaus, Andreas Schwarzer, Gabriele Margareta Siegler, Alexander Kleger et al. · 2025 · Molecular Cancer
Hybrid regulatory T cells: camouflaged architects of tumor immunity
Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, José Roberto Kfoury, Ephraim Abrokwa Ansa-Addo · 2025 · Frontiers in Immunology
Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data
Yaowu Zhu, Li Tan, Danju Luo, Xiong Wang · 2024 · Diagnostics
The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: A retrospective short-term outcome analysis
Georges Sinclair, Hamza Benmakhlouf, Marina Brigui, Markus J. Maeurer, Ernest Dodoo · 2018 · Surgical Neurology International
Carboplatin enhances lymphocyte-endothelial interactions to promote CD8+ T cell trafficking into the ovarian tumor microenvironment
Jaron Mark, Daniel T. Fisher, Minhyung Kim, Tiffany Rose Emmons, A.N.M. Nazmul Khan, Emad Alqassim, Kelly L. Singel, Anna Mistarz, Amit Anand Lugade, Haiying Zhan et al. · 2022 · Gynecologic Oncology
Regulation of global CD8+ T‐cell positioning by the actomyosin cytoskeleton
Jens Volker Stein, Nora Ruef · 2019 · Immunological Reviews
A Fever-Th17 Cell Immune Axis: Some SMADs Like It Hot
Sharon S. Evans, Michelle M. Appenheimer · 2020 · Immunity
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D. Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito · 2024 · Cancer Research Communications
Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1
Jennifer L. Taylor, Kathleen M. Kokolus, Per H. Basse, Jessica N. Filderman, Chloe E. Cosgrove, Simon C. Watkins, Andrea A. Gambotto, Devin B. Lowe, Robert P. Edwards, Paweł Kaliński et al. · 2024 · Vaccines
The single-cell immune landscape of HIV-associated aggressive B-cell lymphoma
Xiaomei Zhang, Zailin Yang, Xiaoqing Xie, Jun Li, Qing Xiao, Guofa Xu, Ben Ma, Xudong Xie, Yi Liu, Liuyue Zhai et al. · 2025 · Journal of the National Cancer Center
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model
Hiroki Satooka, Hirohito Ishigaki, Kagefumi Todo, Koji Terada, Yasutoshi Agata, Yasushi Itoh, Kazumasa Ogasawara, Takako Hirata · 2020 · Scientific Reports
A novel risk score predicts prognosis in melanoma: The combination of three tumor-infiltrating immune cells and four immune-related genes
Wu Pin, Jiaying Cai, Shengjun Fan, Qian Liu, Tianru Huyan, Yao He, Xuejun Li, Long Zhang, Jing Su, Lu Tie · 2021 · Clinical Immunology
Neoantigen identification and TCR-T therapy development for solid tumors: current advances and future perspectives
Xinyao Zheng, Yahui Zhao, Zhihua Liu · 2025 · Journal of the National Cancer Center
Progress and prospects of the combination of BMI1-targeted therapy and immunotherapy in cervical cancer
Yingying Chen · 2025 · American Journal of Cancer Research
Human intravital microscopy in the study of sarcomas: an early trial of feasibility
Emmanuel M Gabriel, Kulkaew Sukniam, Kyle Popp, Sanjay Prakash Bagaria · 2023 · Frontiers in Oncology
Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production
Paurvi Shinde, Wenhai Liu, Antoine Ménoret, Andrew David Luster, Anthony T. Vella · 2017 · Journal of Leukocyte Biology
CXCR3: Here to stay to enhance cancer immunotherapy?
Meri Rogava, Benjamin Izar · 2019 · EBioMedicine
Emerging hallmark of gliomas microenvironment in evading immunity: a basic concept
Muhammad Reza Arifianto, Rizki Meizikri, Irwan Barlian Immadoel Haq, Rahadian Indarto Susilo, Joni Wahyuhadi, Yulius Hermanto, Ahmad Faried · 2023 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets
Zoila Areli Lopez Bujanda, Shawn H. Hadavi, Vicenç Ruiz de Porras, Eva Martinez‐Balibrea, Matthew C. Dallos · 2024 · International review of cytology
Temperature Plays an Essential Regulatory Role in the Tumor Immune Microenvironment
Bin Zhang, Youpeng Wang, Ziyin Zhao, Bing Han, Jinbo B. Yang, Yang Sun, Bingyuan Zhang, Yunjin Zang, Huashi Guan · 2021 · Journal of Biomedical Nanotechnology
Moving towards the Future of Radio-Immunotherapy: Could We “Tailor” the Abscopal Effect on Head and Neck Cancer Patients?
Marco De Felice, Mariagrazia Tammaro, Davide Leopardo, Giovanni Pietro Ianniello, Giacinto Turitto · 2021 · Immuno
Explaining the Paucity of Intratumoral T Cells: A Construction Out of Known Entities
Douglas T. Fearon · 2016 · Cold Spring Harbor Symposia on Quantitative Biology
Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy
Suyang Guo, Wentao Bai, Fengjie Cui, Xin Chen, Xiaojing Fang, Honghong Shen, Xianhua Gu · 2024 · Pharmacogenomics and Personalized Medicine
Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model
Wanqiong Chen, Limian Hong, Shaomei Lin, Na Xian, Cailing Yan, Ningning Zhao, Yonglei Xiao, Wanting Liao, Yuxiang Huang, Mingzhu Chen · 2025 · Frontiers in Oncology
RORγt agonist LYC-55716 potentiates IFN-α’s efficacy in hepatocellular carcinoma through enhancing cytotoxicity of Tc17 cells and infiltration of CD8+ T cells
Heng Wang, Guojiang Zhang, Cai Zhao, Youan Xue, Di Zhu, Yan Chang · 2025 · Biochemical Pharmacology
Synergy between TLR3-ligand and IFN-α in the transient sensitization of “Cold” tumors to PD-1 blockade and the induction of systemic immunity
Kathleen M. Kokolus, Connor J Huck, Eoghan Connors, Eduardo Cortes Gomez, Jianmin Wang, Nataša Obermajer, Per H. Basse, Paweł Kaliński · 2025 · Journal for ImmunoTherapy of Cancer
β-Glucan nanotubes loaded with iron diselenide for enhanced photothermal and photodynamic therapy in hepatocellular carcinoma
Yuxiang Ning, Aokang Yang, Shujun Zhou, Yunhao Wang, Ziguo Lin, Xiaojuan Xu, Yanfeng Wang · 2025 · Acta Biomaterialia
CXCL9 is a dual‑role biomarker in colorectal cancer linked to mitophagy and modulated by ALKBH5
Geng Hu, Shijun Shen, Mingchao Zhu · 2025 · Molecular Medicine Reports
Manipulation of the immune system by non-small cell lung cancer and possible therapeutic interference
Helmut Popper · 2020 · Cancer Drug Resistance
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
Wenjie Gong, Lei Wang, Sophia Stock, Ming Ni, Maria‐Luisa Schubert, Brigitte Neuber, Christian Kleist, Angela Hückelhoven‐Krauss, Depei Wu, Carsten Müller‐Tidow et al. · 2021 · Cells
BPIFB2 is highly expressed in “cold” lung adenocarcinoma and decreases T cell chemotaxis via activation of the STAT3 pathway
Jingwen Zhang, Ping Yü, Qitai Zhao, Ru Guo, Jiqi Shan, Fengsen Liu, Jia Wang, Yi Zhang · 2022 · Molecular and Cellular Probes
Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8+ T lymphocytes infiltration
Jing Luo, Xiuhuan Shi, Yumeng Liu, Jian Wang, Hao Wang, Xuena Yang, Qian Sun, Zhenzhen Hui, Feng Wei, Xiubao Ren et al. · 2024 · Frontiers in Immunology
Non-immune targeting of CXCR3 compromises mitochondrial function and suppresses tumor growth in glioblastoma
Travis Yui Hei Chan, Bo Chen, Wanjun Tang, Henry Hei Chan, Yuk Wong, Ethan C. L. Wong, Junbo Liao, Anson Cho Kiu Ng, Jenny Sum Yee Wong, Gkk Leung et al. · 2025 · Cell Death Discovery
Nanomedicine-mediated co-expression of a PD-1 blockade agent and CXCL9 synergizes T cell infiltration and activation in solid tumors
Yan Wang, Liang Zhao, Jia-Yu Luo, Jie Li, Xinya Gao, Hui-Xiao Li, Yue Zheng, Jiawei Liu · 2025 · Biomaterials Science
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer
Xiao-Peng Sun, Andres A. Ocampo, Ann Hanna, Brandie C. Taylor, Jacey L. Marshall, Julia A. Steele, M. Axelrod, Elizabeth C. Wescott, S. Opalenik, A. DeMichele et al. · 2026 · Science Translational Medicine
Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma
Emmanuel M Gabriel, Deborah A. Bahr, Hari Krishnareddy Rachamalla, Vijay Sagar Madamsetty, Barath Shreeder, Sanjay Prakash Bagaria, Amber L. Escobedo, Joel M. Reid, Debabrata Mukhopadhyay · 2024 · ACS Biomaterials Science & Engineering
Tumor-targeted delivery of CXCL10 by mesenchymal stromal cells potentiates adoptive T cell therapy to treat solid tumors
Jeong Ho Yoon, Gyu‐Bum Yeon, Hojae Lee, Hyunseo An, Jiwon Oh, Seok-Jin Kang, In-Byung Park, Seon Ah Lim, Soo Seok Hwang, Dae‐Sung Kim et al. · 2025 · Biomedicine & Pharmacotherapy
Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
Likun Cui, Liye Zhu, Jie Chen, Chunzhen Li, Yizhi Yu, Sheng Xu · 2023 · Genes
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
Кулемзин Сергей Викторович, Igor Evsyukov, Беловежец Татьяна Николаевна, Alexander V. Taranin, Andrey A. Gorchakov · 2021 · Journal of Personalized Medicine
Single-cell transcriptomics reveal distinct subsets of activated dendritic cells in the tumor microenvironment
Tsun Ki Jerrick To, Samir Devalaraja, Ian Wesley Folkert, Li Zhai, Graham P. Lobel, Malay Haldar · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Development of therapeutic cancer vaccines based on cancer immunity cycle
Jing Zhang, Yiyuan Zheng, Lili Xu, Jing Gao, Zhuoyu Ou, Mingzhao Zhu, Wenjun Wang · 2025 · Frontiers of Medicine
AURKA Enhances Antitumor Immunity by Activating CD4+ T Cell Proliferation in Colorectal Cancer
Yidong Xu, Wei Wang, Jiazi Yu, Jianpei Zhao, Xiaoyu Dai, Zhongchen Liu · 2025 · Cancer Investigation
CCR2 improves tumor directed CAR-T cell trafficking in ovarian cancer
Raj Kumar, Irva E. Veillard, Mengyao Xu, Linah Al-Alem, Bo R. Rueda, Oladapo Yeku · 2025 · Frontiers in Pharmacology